Previous 10 | Next 10 |
home / stock / stssw / stssw news
ORLANDO, FL / ACCESSWIRE / May 19, 2023 / RedChip Companies will air new interviews with Sharps Technology, Inc. (NASDAQ:STSS; STSSW) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 20, at 7 p.m. Eastern Time (ET). Bloombe...
Commercial revenue from specialty safety syringe systems is advancing Company to launch its vial draw syringe systems in Q2 2023 Launch of high-value, next-generation polymer-based products expected in Q3 2023 NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ...
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, appoints Justin Page as V...
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, today announced that it c...
NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, today announced that it e...
First product shipped from Sharps' facility in Hungary and first to support the Nephron Pharmaceuticals distribution and sales collaboration Sharps anticipates 1.3 million units to be commercially available in February 2023 with additional shipments to follow and new products to be added ...
High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond Company to launch next generation specialty polymer-based syringe products for the healthcare market NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “...
Company now transitions from a pre-revenue research & development start-up to a revenue generating manufacturing company Shipments to commence by the end of the year to support the recently announced distribution and sales agreement with Nephron Pharmaceuticals and its European cust...
Company anticipates products to be available in the first quarter of 2023 with initial revenue from this agreement expected in the first half of the year Strengthens the collaboration between Sharps and Nephron to advance the previously announced Inject-EZ startup in South Carolina in e...
WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patente...
News, Short Squeeze, Breakout and More Instantly...
Sharps Technology Inc. Warrant Company Name:
STSSW Stock Symbol:
NASDAQ Market:
Sharps Technology Inc. Warrant Website:
Robert Hayes issues a letter to shareholders asking their voting approval on three proposals vital to the Company’s continued growth. Voting deadline is Friday, July 12, at 11:59 p.m. Eastern Time. NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (N...
Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies issues purchase orders for 1mL SecureGard ultra-low waste, smart safety syringes First 100k unit shipment is scheduled for late July, with the balance to be shipped throughout Q3 and Q4 of this year ...
All shareholders of record as of May 17, 2024 are eligible to vote Final votes must be cast by 11:59 p.m., Eastern Time on July 12, 2024 NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW’) (the “...